Elicio Therapeutics ELTX Ratios (2020-2026)

NASDAQ ELTX
$2.11 -0.07 (-3.23%)
As of: Sep 10, 2026 · 3:59 PM EDT
Reported Financials

Elicio Therapeutics Quarterly Ratios

Periods 26 quarters
Latest Jun 2026

Elicio Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
100.00%98.33%
EBT Margin
-1,079.32%56.41%-878.94%-1,117.76%
EBIT Margin
-1,079.32%56.41%-878.94%-954.36%
EBITDA Margin
-1,079.32%56.41%-878.94%-954.36%
Operating Margin
-1,079.32%56.41%-878.94%-954.36%
Net Margin
-1,079.32%56.41%-878.94%-1,117.76%
FCF Margin
-1,045.21%-55.50%-948.12%849.77%
Efficiency
Assets AverageAssets Avg.
117.65M103.23M88.89M76.04M66.06M41.99M32.22M39.69M34.30M29.07M25.81M20.11M27.07M33.28M28.16M28.84M28.91M27.07M24.28M27.01M
Invested CapitalInvested Cap.
64.51M-74.54M8.72M11.17M13.54M11.04M8.04M17.47M
Asset Utilization RatioAsset Util.
0.020.270.330.390.430.050.02
Leverage & Solvency
Interest Coverage RatioInterest Cover
-5.84-5.35-64.79-22.82-10.89-0.01M-0.00M-284.47-222.94-75.50-57.59-61.00-52.02-18.88-26.24-26.05-25.44
Debt Ratio
0.710.320.340.360.420.30
Times Interest Earned
-5.84-5.35-64.79-22.82-10.89-0.01M-0.00M-284.47-222.94-75.50-57.59-61.00-52.02-18.88-26.24-26.05-25.44
Valuation
Price to EarningsP/E
-3.49-6.73-4.53-7.67-3.89-6.64-4.10-7.45-12.41-22.83-15.44-18.36-8.00
Price to BookP/B
1.255.333.7115.95-25.52-3.60-4.978.9668.4649.4886.61-138.6610.79
Enterprise Value
7.78M54.26M28.55M65.12M38.34M40.99M37.45M60.74M103.46M168.20M123.13M184.31M62.14M
EV to EBIT
-1.00-5.04-3.04-6.36-3.51-3.96-2.78-5.66-10.25-20.91-13.93-17.38-5.96
EV to EBITDA
-1.00-5.04-3.04-6.36-3.51-3.96-2.78-5.66-10.25-20.91-13.93-17.38-5.96
Market Capitalization
29.46M70.80M42.17M77.67M42.16M68.32M56.25M79.78M125.55M188.81M141.69M199.26M85.64M
Price to FCFP/FCF
-3.04-13.54-4.26-6.49-5.35-10.95-6.43-7.88-14.03-16.77-20.85-16.79-10.71
EV to FCF
-0.80-10.37-2.89-5.44-4.86-6.57-4.28-6.00-11.56-14.94-18.11-15.53-7.77
EV to CFO
-0.82-10.46-2.89-5.37-4.29-5.63-4.28-6.00-11.56-15.17-18.11-15.83-7.61
Return Ratios
Return on Sales [ROS]ROS
-1,079.32%56.41%-878.94%-954.36%-41.97%-1,410.17%-3,946.09%
Return on Capital Employed [ROCE]ROCE
-67.99%-42.76%-43.12%-32.00%-20.48%-92.39%-85.37%-85.10%-141.62%-185.10%-192.23%-329.83%-226.61%-206.73%-271.55%-236.07%-189.13%-198.88%-220.46%-212.93%
Return on Assets [ROA]ROA
-57.62%-38.08%-38.09%-30.13%-21.17%-82.45%-87.76%-74.13%-96.53%-125.35%-148.86%-202.87%-149.91%-135.11%-161.73%-155.45%-148.07%-141.36%-158.27%-144.41%